{"prompt": "['Aimmune Therapeutics, Inc.', 'AR101', 'ARC009 Protocol Amend 1.0', '11 Apr 2018 - FINAL', 'Aimmune Confidential Information', 'Page 104 of 122', 'Appendix 2: Real-World Food Challenge Procedures', 'The real-world peanut challenge (RWPC) is designed to closely mimic an accidental', 'exposure to peanut. While food challenges using measured, increasing doses of peanut', 'protein are designed to assess tolerance, how such graded challenges predict outcomes to an', 'accidental exposure is poorly understood. The acceptable and safe procedures for study', 'subjects participating in RWPCs as part of this protocol are described herein; additional', 'procedures may be required as specified in the protocol schedule of activities.', 'The RWPCs conducted under this protocol will follow procedures consistent with the', 'Practical Allergy (PRACTALL) guidelines for safety, assessment, and scoring', '(Sampson, 2012). Subjects will consume a food of their choice containing 500 to 600 mg of', 'peanut protein; examples are shown in Table 1. The study site will provide the foods used in', 'the RWPC.', 'Table 1: Example Foods Containing 500 to 600 mg of Peanut Protein', 'Food', 'Amount of Food Equivalent to 500-600 mg of Peanut Protein', 'Dry-roasted peanut', '2 peanut kernels', '0.5 teaspoon or', 'Peanut butter', '1/2 TSP', '2.5 grams', \"Peanut M&M's\", '2 pieces', '1 peanut kernel', 'PROCEDURES', 'General Safety Considerations', 'A study physician will supervise all RWPCs.', 'Personnel involved in an RWPC must be specifically trained in the management of acute', 'allergic reactions.']['Aimmune Therapeutics, Inc.', 'AR101', 'ARC009 Protocol Amend 1.0', '11 Apr 2018 - FINAL', 'Aimmune Confidential Information', 'Page 105 of 122', 'All necessary medications for treatment of an allergic reaction and resuscitation equipment', 'must be readily available, including epinephrine, oxygen, antihistamines (both H1 and H2),', 'beta-adrenergic agonists, corticosteroids, and intravenous (IV) fluids.', 'PREPARATION FOR THE RWPC', 'Before the Day of the RWPC', 'Determine eligibility:', 'Verify that signed informed consent/assent to participate in the optional RWPC is in', \"the subject's source documents.\", 'Confirm the subject completed the protocol-specified open-label food challenge', '(OLFC) and tolerated the 1000 mg dose without dose-limiting symptoms.', 'Contact the subject and parent/caregiver: Study site staff should schedule the RWPC', 'mindful of visit windows. Study site staff should inform the subject and parent/caregiver in', 'advance of the scheduled RWPC to communicate the following:', 'Review the events of the day (eg, study procedures, modality of the RWPC,', 'possibility of extended observation) and address any potential problems.', \"Confirm and document the appointment date and time in the subject's source\", 'documents.', 'Explain that the RWPC will be rescheduled in the case of illness or symptoms such as', 'wheezing, fever, vomiting, and diarrhea; the subject or parent/caregiver is to notify', 'the study site if such symptoms develop before the RWPC.', \"Establish that the subject's other atopic diseases (eg, asthma, eczema, rhinitis) are\", 'stable.', 'Instruct that the subject is to avoid antihistamines and other current medications that', 'may affect safety or interfere with the RWPC assessment for 5 half-lives of the', 'medication before the RWPC. Review the prescribing information to determine the', \"half-life of each medication for the subject's relevant age group.\", 'Instruct the subject to continue administration of study product at the usual time.', \"Confirm the subject's choice of RWPC food (Table 1) and ensure its availability at\", 'the study site.', 'On the Day of the RWPC', '1. Check the protocol schedule of activities and complete any required procedures as', 'specified before starting the RWPC.', '2. Confirm the following:', 'No recent or active illnesses. Reschedule the RWPC if the subject is experiencing', 'symptoms of an acute infection (eg, fever, recent nausea, vomiting, diarrhea) or any', \"other illness that may interfere with the subject's safety or interpretation of the\", 'results. Do not conduct the RWPC if illness is suspected.']['Aimmune Therapeutics, Inc.', 'AR101', 'ARC009 Protocol Amend 1.0', '11 Apr 2018 - FINAL', 'Aimmune Confidential Information', 'Page 106 of 122', 'Control of chronic atopic diseases. Do not proceed with the RWPC if the subject is', 'experiencing unstable or exacerbated atopic disease such as asthma, atopic dermatitis,', 'urticaria, or allergic rhinitis. Reschedule the RWPC and initiate appropriate actions', 'to control disease activity in the interval.', 'No recent exacerbation for asthma specifically (no rescue albuterol for 2 days, no oral', 'steroid rescue use within 14 days).', 'Avoidance of antihistamines and other medications that may affect the RWPC for', '5 half-lives of the medication before the challenge day.', '3.', 'Obtain baseline vital signs (blood pressure, heart rate, temperature).', '4. Perform a symptom-directed physical examination to confirm an adequate baseline.', '5. Obtain peak expiratory flow rate (PEFR) measurement.', \"For subject aged > 6 years, make 3 attempts and document them in the subject's\", 'source documents. The PEFR must be at least 80% of the predicted value or personal', 'best. If the PEFR is < 80% of the predicted value or personal best, reschedule the', 'RWFC.', 'For subject aged 4 to 5 years, attempt to measure PEFR and document it in the', \"subject's source documents (if unable to successfully obtain, record attempts and\", 'investigator assessment).', '6. Place a saline lock if directed by the supervising physician for subjects considered at high', 'risk of allergic reaction or severe reaction based on medical history.', '7. Ensure rescue medications and resuscitation equipment are available and readily', 'accessible, including epinephrine, diphenhydramine (oral, IV), cetirizine (oral), albuterol', '(nebulizer or as a metered dose inhaler), IV supplies and fluids, oxygen, and suction.', 'Calculate appropriate weight-based doses of emergency medications in advance for', 'treatment of reactions.', 'Prepare an appropriate dose of epinephrine at a 1:1000 effective concentration for', 'intramuscular use and have it readily accessible. An epinephrine auto-injector or', 'epinephrine in ampules/vials prepared in syringes are acceptable.', '8. Prepare the RWFC food option (Table 1) that the subject selected for the procedure.', 'DOSING AND MONITORING DURING THE RWPC PROCEDURE', '1. Measure and record vital signs (blood pressure, heart rate, temperature) immediately', 'before providing the RWPC food.', '2. Provide the selected food and instruct the subject to completely consume it within', 'a 10-minute period.', '3. Monitor for signs and symptoms of an allergic reaction for a minimum of 2 hours after', 'the subject fully consumes the food. Measure vital signs (blood pressure, heart rate,', 'temperature) approximately every 30 minutes and assess for signs or symptoms of an', 'allergic reaction.']\n\n###\n\n", "completion": "END"}